Titre : Maladie gravidique précoce

Maladie gravidique précoce : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Maladie gravidique précoce : Questions médicales les plus fréquentes", "headline": "Maladie gravidique précoce : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Maladie gravidique précoce : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-06", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Maladie gravidique précoce" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vomissement", "url": "https://questionsmedicales.fr/mesh/D014839", "about": { "@type": "MedicalCondition", "name": "Vomissement", "code": { "@type": "MedicalCode", "code": "D014839", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.821.937" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hyperémèse gravidique", "alternateName": "Hyperemesis Gravidarum", "url": "https://questionsmedicales.fr/mesh/D006939", "about": { "@type": "MedicalCondition", "name": "Hyperémèse gravidique", "code": { "@type": "MedicalCode", "code": "D006939", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.821.937.049.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Maladie gravidique précoce", "alternateName": "Morning Sickness", "code": { "@type": "MedicalCode", "code": "D048968", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Dae Yul Kim", "url": "https://questionsmedicales.fr/author/Dae%20Yul%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea." } }, { "@type": "Person", "name": "Min Ho Chun", "url": "https://questionsmedicales.fr/author/Min%20Ho%20Chun", "affiliation": { "@type": "Organization", "name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea." } }, { "@type": "Person", "name": "JaYoung Kim", "url": "https://questionsmedicales.fr/author/JaYoung%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea." } }, { "@type": "Person", "name": "T Requena", "url": "https://questionsmedicales.fr/author/T%20Requena", "affiliation": { "@type": "Organization", "name": "Departamento de Biotecnología y Microbiología de Alimentos, Instituto de Investigación en Ciencias de la Alimentación (CIAL-CSIC), Madrid, España. Electronic address: t.requena@csic.es." } }, { "@type": "Person", "name": "M Velasco", "url": "https://questionsmedicales.fr/author/M%20Velasco", "affiliation": { "@type": "Organization", "name": "Sección de Enfermedades Infecciosas, Medicina Interna, Hospital Universitario Fundación Alcorcón, Alcorcón, España." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Diagnosis and Pathologic Reporting of Prostate Cancer in the Era of MRI-Targeted Prostate Biopsy.", "datePublished": "2022-10-13", "url": "https://questionsmedicales.fr/article/36344178", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.path.2022.07.002" } }, { "@type": "ScholarlyArticle", "name": "Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35926810", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.humpath.2022.07.018" } }, { "@type": "ScholarlyArticle", "name": "Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia.", "datePublished": "2022-06-16", "url": "https://questionsmedicales.fr/article/36326314", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.55730/1300-0144.5374" } }, { "@type": "ScholarlyArticle", "name": "Causal relationship between prostatic diseases and prostate cancer: a mendelian randomization study.", "datePublished": "2024-06-27", "url": "https://questionsmedicales.fr/article/38937672", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-024-12551-9" } }, { "@type": "ScholarlyArticle", "name": "Prostate MRI for the detection of clinically significant prostate cancer: Update and future directions.", "datePublished": "2024-04-25", "url": "https://questionsmedicales.fr/article/39032957", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/bs.acr.2024.04.002" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Signes et symptômes digestifs", "item": "https://questionsmedicales.fr/mesh/D012817" }, { "@type": "ListItem", "position": 5, "name": "Vomissement", "item": "https://questionsmedicales.fr/mesh/D014839" }, { "@type": "ListItem", "position": 6, "name": "Maladie gravidique précoce", "item": "https://questionsmedicales.fr/mesh/D048968" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Maladie gravidique précoce - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Maladie gravidique précoce", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Maladie gravidique précoce", "description": "Comment diagnostiquer la maladie gravidique précoce ?\nQuels examens sont nécessaires pour le diagnostic ?\nQuand consulter un médecin pour des nausées ?\nLes nausées matinales sont-elles normales ?\nPeut-on confondre avec d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Maladie gravidique précoce", "description": "Quels sont les symptômes typiques ?\nLes symptômes varient-ils d'une femme à l'autre ?\nLes nausées surviennent-elles à tout moment ?\nY a-t-il des symptômes associés ?\nLes vomissements sont-ils fréquents ?", "url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Maladie gravidique précoce", "description": "Peut-on prévenir les nausées matinales ?\nQuels aliments éviter pour réduire les symptômes ?\nLe stress influence-t-il les nausées ?\nL'hydratation aide-t-elle à prévenir les nausées ?\nLes vitamines peuvent-elles aider ?", "url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Maladie gravidique précoce", "description": "Quels traitements sont disponibles ?\nLes remèdes naturels sont-ils efficaces ?\nQuand utiliser des médicaments ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements sont-ils sûrs pendant la grossesse ?", "url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Maladie gravidique précoce", "description": "Quelles complications peuvent survenir ?\nComment reconnaître une complication ?\nLes complications affectent-elles le bébé ?\nQuelles sont les conséquences d'une déshydratation ?\nL'hyperémèse gravidique est-elle fréquente ?", "url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Maladie gravidique précoce", "description": "Quels sont les facteurs de risque connus ?\nL'âge de la mère influence-t-il les nausées ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?\nLes femmes fumeuses sont-elles plus à risque ?", "url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la maladie gravidique précoce ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur les symptômes rapportés par la patiente et l'exclusion d'autres causes." } }, { "@type": "Question", "name": "Quels examens sont nécessaires pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Aucun examen spécifique n'est requis, mais des analyses sanguines peuvent être faites si nécessaire." } }, { "@type": "Question", "name": "Quand consulter un médecin pour des nausées ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de consulter si les nausées sont sévères ou persistent au-delà du premier trimestre." } }, { "@type": "Question", "name": "Les nausées matinales sont-elles normales ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont fréquentes et généralement considérées comme normales durant la grossesse." } }, { "@type": "Question", "name": "Peut-on confondre avec d'autres maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est important d'exclure d'autres causes comme des infections ou des troubles digestifs." } }, { "@type": "Question", "name": "Quels sont les symptômes typiques ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, vomissements, fatigue et hypersensibilité aux odeurs." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une femme à l'autre ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la durée des symptômes peuvent varier considérablement entre les femmes." } }, { "@type": "Question", "name": "Les nausées surviennent-elles à tout moment ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Bien que souvent matinales, les nausées peuvent survenir à tout moment de la journée." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des maux de tête ou des changements d'humeur peuvent également apparaître." } }, { "@type": "Question", "name": "Les vomissements sont-ils fréquents ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les vomissements peuvent survenir chez certaines femmes, mais ne sont pas systématiques." } }, { "@type": "Question", "name": "Peut-on prévenir les nausées matinales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode garantie, mais des changements alimentaires peuvent aider." } }, { "@type": "Question", "name": "Quels aliments éviter pour réduire les symptômes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments gras, épicés et les odeurs fortes qui peuvent aggraver les nausées." } }, { "@type": "Question", "name": "Le stress influence-t-il les nausées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les symptômes, il est donc conseillé de pratiquer des techniques de relaxation." } }, { "@type": "Question", "name": "L'hydratation aide-t-elle à prévenir les nausées ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, rester bien hydraté peut aider à réduire l'intensité des nausées." } }, { "@type": "Question", "name": "Les vitamines peuvent-elles aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vitamines, comme la vitamine B6, peuvent aider à réduire les symptômes chez certaines femmes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des changements alimentaires, des médicaments anti-nauséeux et l'hydratation." } }, { "@type": "Question", "name": "Les remèdes naturels sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des remèdes comme le gingembre ou les tisanes peuvent aider à soulager les symptômes." } }, { "@type": "Question", "name": "Quand utiliser des médicaments ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments sont recommandés si les symptômes sont sévères et affectent la qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent avoir des effets secondaires, il est donc important de consulter." } }, { "@type": "Question", "name": "Les traitements sont-ils sûrs pendant la grossesse ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La plupart des traitements sont considérés comme sûrs, mais il est essentiel de consulter un médecin." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la déshydratation ou l'hyperémèse gravidique peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Comment reconnaître une complication ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des vomissements fréquents, une perte de poids ou des douleurs abdominales nécessitent une consultation." } }, { "@type": "Question", "name": "Les complications affectent-elles le bébé ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Dans les cas graves, des complications peuvent affecter la santé du bébé, d'où l'importance d'un suivi médical." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une déshydratation ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation peut entraîner des complications graves, y compris des problèmes rénaux et des déséquilibres électrolytiques." } }, { "@type": "Question", "name": "L'hyperémèse gravidique est-elle fréquente ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'hyperémèse gravidique est rare mais nécessite une attention médicale immédiate." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents de nausées dans des grossesses précédentes et des grossesses multiples." } }, { "@type": "Question", "name": "L'âge de la mère influence-t-il les nausées ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes plus jeunes, notamment celles de moins de 20 ans, peuvent être plus à risque." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un historique familial de nausées matinales peut augmenter le risque chez la mère." } }, { "@type": "Question", "name": "Le stress peut-il être un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress émotionnel et physique peut augmenter la probabilité de développer des nausées." } }, { "@type": "Question", "name": "Les femmes fumeuses sont-elles plus à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut influencer l'intensité des nausées matinales chez certaines femmes." } } ] } ] }

Sources (10000 au total)

Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia.

It is a known fact that the role of microRNAs (miRNA) has a very important place in cancer development and progression. miRNAs target a significant part of pathways as well as genes. This study aimed ... Peripheral blood mononuclear cells (PBMCs) and tissue samples were collected from prostate cancer (PCa) (n: 20) and benign prostatic hyperplasia (BPH) (n: 20) patients. Total RNA isolation was perform... In tissue samples, 37 different expressed miRNAs were identified in PCa patients compared to BPH patients. In PBMCs samples, 27 different expressed miRNAs were identified in PCa patients compared to b... Our results suggested that determined common hsa-miR-494-3p, hsa-miR-3128, hsa-miR-8084 and their target HIF1A, AVRP1A, NHS, INSL4 may play a crucial role in therapeutic and early diagnostic strategie...

Causal relationship between prostatic diseases and prostate cancer: a mendelian randomization study.

Although it is thought that prostatitis or benign prostatic hyperplasia (BPH) is related to prostate cancer (PCa), the underlying causal effects of these diseases are unclear.... We assessed the causal relationship between prostatitis or BPH and PCa using a two-sample Mendelian randomization (MR) approach. The data utilized in this study were sourced from genome-wide associati... MR analysis showed that BPH had a significant causal effect on PCa (Odds Ratio = 1.209, 95% Confidence Interval: 0.098-0.281, P = 5.079 × 10... This MR study supports that BPH has a positive causal effect on PCa, while genetically predicted prostatitis has no causal effect on PCa. Nonetheless, further studies should explore the underlying bio...

Prostate MRI for the detection of clinically significant prostate cancer: Update and future directions.

In recent decades, there has been an increasing role for magnetic resonance imaging (MRI) in the detection of clinically significant prostate cancer (csPC). The purpose of this review is to provide an... In diagnosing clinically significant prostate cancer pre-biopsy, advances include our understanding of MRI-targeted biopsy, the role of biparametric MRI (non-contrast) and changing indications, for ex... The utility of MRI in detecting csPC has been demonstrated in many clinical scenarios, initially from simply diagnosing csPC pre-biopsy, now to screening, active surveillance, clinical staging, and de...

Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer.

For metastatic hormone naïve prostate cancer patients, androgen deprivation therapy (ADT) with escalation therapy including docetaxel and/or androgen targeting drugs is the standard therapy. However, ... Prostate biopsies from 92 patients with metastatic hormone naïve PC (PSA > 80 ng/mL or clinical metastases) were immunohistochemically evaluated for PSA and Ki67. Gene expression analysis was performe... The immunohistochemical score for PSA was the strongest prognostic factor for progression-free and overall survival after ADT. Consequently, the ratio between Ki67 and PSA displayed a stronger prognos... PSA and Ki67 immunoreactive scores are prognostic in the metastatic hormone-sensitive setting, with PSA being superior. The combination of Ki67 and PSA did not give additional prognostic value. The re...

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer.

To investigate the value of serum free prostate-specific antigen density (fPSAD) in the diagnosis of prostate cancer (PCa).... The data of 558 patients who underwent transrectal ultrasound-guided prostate biopsy were retrospectively analyzed. According to the pathological results, the patients were divided into a PCa group an... tPSA, PSAD, (f/t)/PSAD, and fPSAD had high accuracy in predicting PCa with AUC values of 0.820, 0.900, 0.846, and 0.867. fPSAD showed lower diagnostic sensitivity but significantly higher specificity ... With the optimal cutoff value of 0.062, fPSAD has a higher diagnostic value for PCa than tPSA, f/tPSA, (f/t)/PSAD, and PSAD, and can well predict the risk of PCa, significantly improve the clinical di...

[Structured reporting of prostate cancer-self-development of a digital solution for prostate biopsies].

The challenges in pathology and in structuring of data are increasing. Although considerable amounts of data are generated during the pathological diagnostic process, these data are often not availabl... The aim of the work was the development of a digital system for the direct and high-quality acquisition of structured pathology data using the example of biopsy-based diagnostics of prostate carcinoma... A solution was created in cooperation with the pathology laboratory information system (LIS) provider imassense GmbH (Berlin, Germany), whose LIS 'Informationssystem der digitalen Pathologie' (IS-P) i... Over a period of about 1.5 years, a system that is capable of structured reporting according to local, national (S3 guidelines, German Cancer Society) and international (International Collaboration on...

Therapy decisions after diagnosis of prostate cancer in men with negative prostate MRI.

To investigate the clinical implications of magnetic resonance imaging (MRI) negative prostate cancer (PCa) in a cohort of men undergoing transperineal prostate biopsy.... We included all men without prior diagnosis of PCa undergoing transperineal template saturation ± fusion-guided targeted biopsy of the prostate between November 2014 and March 2018. Before biopsy, all... From 515 patients undergoing prostate biopsy, 171 (33.2%) patients had a negative and 344 (66.8%) a positive MRI. Pathology review stratified for MRI negative and positive cases revealed nsPCa in 27 (... Only few men with MRI negative PCa need active cancer treatment at the time of diagnosis, while the majority opts for AS. Omitting prostate biopsies and performing a follow-up MRI may be a safe altern...